Profile data is unavailable for this security.
About the company
Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
- Revenue in GBP (TTM)170.05m
- Net income in GBP-7.06m
- Incorporated2001
- Employees249.00
- LocationAlliance Pharma PLCAvonbridge House, Bath RoadCHIPPENHAM SN15 2BBUnited KingdomGBR
- Phone+44 124 946 6966
- Fax+44 124 946 6977
- Websitehttps://www.alliancepharmaceuticals.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Futura Medical PLC | 3.10m | -6.51m | 107.17m | 12.00 | -- | 19.56 | -- | 34.56 | -0.0219 | -0.0219 | 0.0105 | 0.0182 | 0.3391 | -- | 4.73 | -- | -71.22 | -79.25 | -127.75 | -127.22 | 57.22 | -- | -210.03 | -914.37 | 1.47 | -- | -- | -- | -- | -- | -11.40 | -- | 219.68 | -- |
| Creo Medical Group PLC | 29.23m | -25.10m | 125.61m | 279.00 | -- | 1.77 | -- | 4.30 | -0.1139 | -0.1139 | 0.126 | 0.1966 | 0.3318 | 1.87 | 4.14 | 102,926.10 | -28.49 | -- | -34.24 | -- | 48.11 | -- | -85.87 | -- | 3.45 | -- | 0.1177 | -- | 7.98 | -- | -9.52 | -- | -- | -- |
| Animalcare Group Plc | 74.35m | 1.20m | 130.43m | 220.00 | 109.76 | 1.67 | 14.80 | 1.75 | 0.0198 | 0.0198 | 1.22 | 1.30 | 0.6608 | 2.63 | 5.54 | -- | 1.07 | 0.3272 | 1.30 | 0.3866 | 58.30 | 53.62 | 1.61 | 0.5484 | 1.05 | 5.44 | 0.0701 | 599.95 | 3.82 | 0.5138 | -38.98 | -- | -11.79 | 2.59 |
| Allergy Therapeutics plc | 53.26m | -50.22m | 133.46m | 635.00 | -- | 5.04 | -- | 2.51 | -0.0266 | -0.0266 | 0.017 | 0.0056 | 0.7571 | 2.21 | 4.92 | 83,870.87 | -71.39 | -11.59 | -102.10 | -15.15 | 52.54 | 70.08 | -94.29 | -11.78 | 0.9281 | -7.93 | 0.2713 | -- | -18.11 | -2.71 | -212.65 | -- | 16.41 | -- |
| 4Basebio PLC | 354.00k | -6.28m | 133.81m | -- | -- | 37.74 | -- | 378.01 | -0.5094 | -0.5094 | 0.0287 | 0.2769 | 0.0296 | 0.3977 | 4.88 | -- | -52.42 | -- | -60.21 | -- | 80.51 | -- | -1,772.60 | -- | 3.28 | -40.29 | 0.6683 | -- | -20.71 | -- | -59.20 | -- | -- | -- |
| Avacta Group Plc | 16.03m | -42.08m | 159.77m | 120.00 | -- | 5.39 | -- | 9.97 | -0.1605 | -0.1633 | 0.0606 | 0.0826 | 0.2406 | 4.50 | 2.38 | 133,541.70 | -63.18 | -- | -119.23 | -- | 54.40 | -- | -262.60 | -- | 0.6603 | -1.66 | 0.6913 | -- | 228.22 | -- | -49.92 | -- | -- | -- |
| Alliance Pharma plc | 170.05m | -7.06m | 191.84m | 249.00 | -- | 0.6924 | 61.25 | 1.13 | -0.0131 | -0.0131 | 0.3145 | 0.5127 | 0.3202 | 2.88 | 4.40 | 682,927.70 | -1.33 | 2.64 | -1.47 | 2.95 | 57.58 | 63.38 | -4.15 | 8.35 | 1.38 | 2.18 | 0.31 | 53.41 | 2.58 | 10.50 | -87.21 | -49.62 | -25.78 | 5.94 |
| hVIVO PLC | 56.04m | 16.12m | 192.21m | 274.00 | 12.08 | 5.60 | 10.21 | 3.43 | 0.0234 | 0.0234 | 0.0817 | 0.0505 | 0.8327 | -- | 4.08 | 204,536.50 | 23.94 | -0.643 | 46.27 | -1.29 | -- | -- | 28.75 | -0.765 | 1.47 | -- | 0.2674 | -- | 15.61 | 35.40 | 2,176.68 | -- | 136.55 | -- |
| Oxford BioMedica plc | 119.02m | -61.63m | 215.00m | 891.00 | -- | 1.21 | -- | 1.81 | -0.6389 | -0.6389 | 1.23 | 1.78 | 0.2743 | 4.67 | 3.09 | 131,662.60 | -16.18 | -4.45 | -21.95 | -5.69 | 46.20 | 53.90 | -58.97 | -8.16 | 3.07 | -9.24 | 0.3635 | -- | -1.97 | 30.08 | -305.97 | -- | 52.60 | -- |
| Bioventix PLC | 13.60m | 8.67m | 233.58m | 16.00 | 27.41 | 20.43 | 26.58 | 17.18 | 1.63 | 1.63 | 2.56 | 2.19 | 1.09 | 1.53 | 2.54 | 849,780.60 | 69.72 | 56.43 | 79.03 | 61.01 | 93.75 | 92.64 | 63.73 | 65.08 | 6.69 | -- | 0.00 | 84.49 | 9.36 | 7.93 | 9.10 | 8.13 | -37.12 | 20.03 |
| Niox Group PLC | 36.80m | 9.50m | 282.39m | 85.00 | 31.60 | 3.13 | 20.32 | 7.67 | 0.0211 | 0.0238 | 0.0819 | 0.2136 | 0.3874 | 2.31 | 6.13 | 432,941.20 | 10.00 | -2.41 | 10.57 | -2.90 | 72.01 | 70.87 | 25.82 | -11.46 | 3.99 | -- | 0.013 | -- | 17.57 | -5.29 | -32.62 | -- | -5.59 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Van Lanschot Kempen Investment Management NV (United Kingdom)as of 06 Nov 2023 | 55.16m | 10.21% |
| Slater Investments Ltd.as of 21 Sep 2023 | 54.12m | 10.02% |
| Van Lanschot Kempen Investment Management NVas of 17 Mar 2023 | 45.63m | 8.45% |
| Rathbones Investment Management Ltd.as of 06 Oct 2023 | 25.97m | 4.81% |
| Fidelity Management & Research Co. LLCas of 17 Mar 2023 | 19.64m | 3.64% |
| Investec Wealth & Investment Ltd.as of 17 Mar 2023 | 17.26m | 3.20% |
| Artemis Investment Management LLPas of 29 Dec 2023 | 16.15m | 2.99% |
| RBC Global Asset Management (UK) Ltd.as of 25 Aug 2023 | 14.55m | 2.69% |
| Rowan Dartington & Co. Ltd. (Broker)as of 02 Dec 2023 | 14.44m | 2.67% |
| Brooks Macdonald Asset Management Ltd.as of 02 Dec 2023 | 12.14m | 2.25% |
